Progentec Diagnostics, Inc.
Our Story Our Research Publications Progentec Presents News
Technology Product Pipeline The aiSLE® DX Family of Tests [AutoimmuneCorner]™ LupusCorner® Research LupusCorner®
Team Board of Directors Advisors Careers
Partner With Us Contact Us
Patient Support
Progentec Research Technologies
About our Laboratory Tests We Offer Order our tests
About Our Story Our Research Publications Progentec Presents News Technologies Technology Product Pipeline The aiSLE® DX Family of Tests [AutoimmuneCorner]™ LupusCorner® Research LupusCorner® Team Team Board of Directors Advisors Careers Partner with Us Partner With Us Contact Us For Patients Patient Support R&D Services Progentec Research Technologies Progentec Lab Services About our Laboratory Tests We Offer Order our tests
Progentec Diagnostics, Inc.
Proteomics and digital health for the proactive care of systemic lupus erythematosus, multiple sclerosis (MS), and autoimmune diseases

Clinical disease activity and flare in SLE: Current concepts and novel biomarkers

Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8044029/

Thanou A, Jupe E, Purushothaman M, Niewold TB, Munroe ME. 2021. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers. J. Autoimmun. 119:102615. PMCID: PMC8044029.

Disease Activity Index (DAI)AdminFebruary 21, 2021PublicationComment
Facebook0 Twitter LinkedIn0
Previous

A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus

Flare Risk Index (FRI)AdminMarch 5, 2023Publication
Next

Ability of Inflammatory and Regulatory Soluble Mediators to Forecast Impending Clinical Disease Flare and Inform a Refined Lupus Flare Prediction Index in a Confirmatory Cohort of SLE Patients

Flare Risk Index (FRI)AdminNovember 10, 2019Abstract
Keep up with Progentec!

 
 

 
progentec-logo-web.png
 

755 Research Parkway, Suite #100, Oklahoma City, OK 73104


Phone: 833-587-8739 EXT 110
Fax: 833.335.3314


info@progentec.com

 
Hours
 

Copyright Progentec Diagnostics, Inc. 2022 All rights reserved

Privacy Policy | Terms & Conditions | Conflict of Interest Policy